Department of Health and Social Care -
The government is proposing updates to the statutory scheme to make sure that the scheme can continue to meet its objectives from 2024 onwards, whether this is alongside a successor voluntary scheme or as a standalone scheme in the absence of this. The consultation sets out proposed amendments in three main areas: increasing the allowed growth rate which will have the effect of changing the payment percentages; revising which sales of branded medicines are exempt from scheme payments; and a new approach to control spending on older branded medicines.